510(k) Report

510(k) · Cleared

Cleared

Magnetom C!

K082331510(k) TraditionalCleared Oct 1, 200848-day reviewClass II21 CFR 892.1000

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Siemens Medical Solutions USA, Inc. · LNH System, Nuclear Magnetic Resonance Imaging

Cleared on Oct 1, 2008 as substantially equivalent to K071925 (Siemens Medical Solutions USA, Inc., 2007) and 1 other predicate after a 48-day review. Its family tree reaches back 6 generations to 1997. 3 later devices descend from it.

Decided
Oct 1, 2008
Review
48 days
Class
Class II
Product code
LNH
Recalls
None
Predicates
2

Its longest line of descent runs back 6 generations to K971684 (1997). 14 ancestors in all, the oldest K970852 (1997). 3 later devices descend from it, 1 citing it directly.

  1. Root · 6 generations backK971684 Magnetom Project 047 System (Numaris 3.5 Software)Siemens Medical Solutions USA, Inc. · 1997 · Recalled
  2. 5 generations backK032428 Magnetom Avanto MR SystemSiemens Medical Solutions USA, Inc. · 2003 · Recalled
  3. 4 generations backK041112 Magnetom Espree SystemSiemens Medical Solutions USA, Inc. · 2004 · Recalled
  4. 3 generations backK052164 Magnetom Systems with Software Syngo MR 2006ASiemens Medical Solutions USA, Inc. · 2005
  5. 2 generations backK062454 Magnetom Systems - I-Class and T-Class ReleasesSiemens Medi Cal Solutions, Inc. · 2006
  6. 1 generation backK071925 Magnetom EssenzaSiemens Medical Solutions USA, Inc. · 2007 · Recalled
  7. This deviceK082331 Magnetom C!Siemens Medical Solutions USA, Inc. · 2008
  8. Descendant · cites it directly · 2 of its ownK190524 MRopen 0.5 TAsg Superconductors S.P.A. · 2019
  9. Descendant · 2 generations on · 1 of its ownK193116 MRopen EVOAsg Superconductors S.P.A. · 2019
  10. Descendant · 3 generations on · 0 of its ownK242258 MROpen Evo (03-2000-00); MROpen Evo (03-4000-00)Asg Superconductors S.P.A. · 2024

Most influential descendants

Showing 3 of 3 · See all
  • K190524MRopen 0.5 TAsg Superconductors S.P.A. · 2019 · cites it directly2descendants
  • K193116MRopen EVOAsg Superconductors S.P.A. · 2019 · 2 generations on1descendant
  • K242258MROpen Evo (03-2000-00); MROpen Evo (03-4000-00)Asg Superconductors S.P.A. · 2024 · 3 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−6K971684Magnetom Project 047 System (Numaris 3.5 Software)Siemens Medical Solutions USA, Inc.19974
−5K032428Magnetom Avanto MR SystemSiemens Medical Solutions USA, Inc.20034
−4K041112Magnetom Espree SystemSiemens Medical Solutions USA, Inc.20044
−3K052164Magnetom Systems with Software Syngo MR 2006ASiemens Medical Solutions USA, Inc.2005—
−2K062454Magnetom Systems - I-Class and T-Class ReleasesSiemens Medi Cal Solutions, Inc.2006—
−1K071925Magnetom EssenzaSiemens Medical Solutions USA, Inc.20071
0 (this device)K082331Magnetom C!Siemens Medical Solutions USA, Inc.2008—
+1K190524MRopen 0.5 TAsg Superconductors S.P.A.2019—
+2K193116MRopen EVOAsg Superconductors S.P.A.2019—
+3K242258MROpen Evo (03-2000-00); MROpen Evo (03-4000-00)Asg Superconductors S.P.A.2024—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
199710
199910
200010
200110
200420
200520

Descendants by year cleared

Year clearedDevicesWith a Class I recall
201920
202410
FIG. 1 — Lineage of K082331, 1997–2024Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in LNH? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new LNH device

  1. #1 K213693 MAGNETOM Vida with syngo MR XA50Ascore 23.0 · 18 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K071925Magnetom Essenza
Summary page 3
…will assure that the performance of this device can be considered safe and effective with respect to the currently available MAGNETOM C!( K043030) and MAGNETOM ESSENZA (K071925). DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service…
Siemens Medical Solutions USA, Inc.20071
*K043030Magnetom C! MR System
Summary page 2
…TOM C! system is an open, whole body scanner designed to support improved higher resolution imaging and shorter scan times, which was described in premarket notification K043030 which received FDA clearance on December, 10, 2004. Siemens intends to modify the RF Infra Structure, RF Signal Unit, Filter Plat…
Siemens Medical Solutions2004—

Also cleared against K071925: 4 other devices →

What descends from it? (3)

1 later device cites it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K190524MRopen 0.5 TAsg Superconductors S.P.A.20192

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 11 years and passes through 2 companies; a new generation was cleared every 1.1 years on median.
  • 8 of the 14 ancestors have a recall of any class.
  • Of its descendants, K190524 (Asg Superconductors S.P.A., 2019) has gone furthest, with 2 descendants of its own.
  • 4 other devices also cite its predicate K071925.

How does its category compare?

All LNH devices

LNH System, Nuclear Magnetic Resonance Imaging: FDA decisions, review times, recalls and adverse event reports over 20 years. 2008, this device’s year, is highlighted.

FDA decisions per year · LNH

26in 2025

2007: 122008: 192009: 172010: 122011: 162012: 222013: 192014: 172015: 192016: 202017: 182018: 292019: 262020: 322021: 272022: 302023: 302024: 262025: 262026 (partial year): 24
2007high 32 (2020) · low 12 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · LNH

122in 2025

2007: 35 days median2008: 53 days median2009: 70 days median2010: 94 days median2011: 81 days median2012: 89 days median2013: 108 days median2014: 108 days median2015: 140 days median2016: 108 days median2017: 98 days median2018: 128 days median2019: 62 days median2020: 121 days median2021: 87 days median2022: 74 days median2023: 124 days median2024: 104 days median2025: 122 days median2026 (partial year): 126 days median
2007high 140 (2015) · low 35 (2007)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · LNH

8in 2025

2007: 252008: 122009: 72010: 172011: 112012: 52013: 22014: 132015: 12, 2 Class I2016: 12018: 712019: 52020: 42021: 412022: 132023: 10, 1 Class I2024: 42025: 8, 5 Class I2026 (partial year): 43
2007high 71 (2018) · low 0 (2017)2026

Class I (8 since 2007) Class II/III not classified

Adverse event reports per year · LNH

1,263in 2025

2007: 1142008: 1672009: 1942010: 1652011: 1822012: 1702013: 1072014: 1192015: 1132016: 1352017: 1212018: 1582019: 1582020: 982021: 842022: 1382023: 1592024: 2812025: 1,263
2007high 1,263 (2025) · low 84 (2021)2025

MAUDE reports naming product code LNH, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
2007123525114
2008195312167
200917707194
2010129417165
2011168111182
201222895170
2013191082107
20141710813119
20151914012 (2)113
2016201081135
201718980121
20182912871158
201926625158
202032121498
202127874184
2022307413138
20233012410 (1)159
2024261044281
2025261228 (5)1,263
20262412643—

What is it indicated for?

The MAGNETOM C! is indicated for use as magnetic resonance diagnostic devices (MRDD) that produce transverse, sagittal, coronal and oblique cross sectional images, and that display the internal structure and/or function of the head, body, or extremities. Depending on the region of interest, contrast agents may be used. These images when interpreted by a trained physician yield information that may assist in diagnosis. The MAGNETOM C! may also be used for…

Read the full statement (113 words)

The MAGNETOM C! is indicated for use as magnetic resonance diagnostic devices (MRDD) that produce transverse, sagittal, coronal and oblique cross sectional images, and that display the internal structure and/or function of the head, body, or extremities. Depending on the region of interest, contrast agents may be used. These images when interpreted by a trained physician yield information that may assist in diagnosis.

The MAGNETOM C! may also be used for imaging during interventional procedures when performed with MR compatible devices such as, in room display and MR safe biopsy needles

Disclaimer: Utility of contrast enhanced breast MRI for the detection of breast masses has not been documented and is thus not indicated.

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K082331: Magnetom C!.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 5, 2026. https://510kreport.com/device/K082331

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026